Red Tree Venture Capital is an early stage-biased life science venture firm that employs a targeted strategy of leveraging its deep relationships with leading West Coast academic and research institutions to source innovation emerging from those organizations.
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Series B
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| 13.04.2024 | Engrail Th... | engrail.com | $253M | United Sta... |
| 09.02.2024 | Contineum ... | contineum-tx.com | - | - |
| 29.06.2023 | Tachyon Th... | tachyontx.com | $11.6M | United Sta... |
| 10.11.2022 | Syncopatio... | syncopationlife.com | $200M | United Sta... |
| 10.11.2022 | Cargo Ther... | cargo-tx.com | - | - |
| 03.11.2022 | Bicara The... | bicara.com | $635M | - |
| 02.03.2022 | Rondo Ther... | rondotx.com | $67M | United Sta... |
| - | Acrigen Bi... | acrigen.com | - | United Sta... |
| - | Ceribell | ceribell.com | $138M | United Sta... |
| - | Alladapt I... | alladapt.com | $119M | United Sta... |
Show more
Persons 6
| Date | First Name | Last Name | Title | Location | |||
| - | Jon | Edwards | Managing D... | linkedin.c... | - | j*n@redtre... | - |
| - | Matt | Potter | CFO | linkedin.c... | - | M**t@redtr... | - |
| - | Jodi | Yang | Head of Ca... | linkedin.c... | - | J**i@redtr... | - |
| - | Krishna | Polu | Principal | linkedin.c... | - | - | - |
| - | Heath | Lukatch | Founder &a... | linkedin.c... | - | H***h@redt... | - |
| - | Yoko | Sugimoto | Executive ... | linkedin.c... | - | y**o@redtr... | - |
News 27
Show more
Mentions in press and media 4
| Date | Title | Description |
| 13.05.2026 | Rondo Therapeutics Doses First Patient in Phase 1 Trial of RNDO-564, a First-in-Class Co-Stimulatory Bispecific Antibody Targeting Nectin-4 in Advanced Solid Tumors | Novel CD28 x Nectin-4 bispecific designed to overcome limitations of ADCs through durable and well-tolerated tumor-directed immune co-stimulation Milestone marks Rondo Therapeutics’ transition to a clinical-stage company HAYWARD, Calif.--(... |
| 19.03.2024 | Engrail Therapeutics raises $157M Series B | Engrail Therapeutics, a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, today announced that it has closed an oversubscribed $157 million Series B financing round. Th... |
| 06.10.2022 | Red Tree Venture Capital Announces Closing of $272 Million Inaugural Fund | - |
| 06.10.2022 | Red Tree Venture Capital Closes Inaugural Fund, at $272M | Red Tree Venture Capital, a West Coast-centric, early stage-biased life science venture capital firm, announced a $272m final close of its inaugural fund, Red Tree Venture Capital Fund I. Founded in 2020 by Heath Lukatch, Ph.D. and Jennifer... |